Skip to main content
Caplight Logo









Peter's Lab

Peter's Lab

Private
UlsanHealthcare & Life Scienceshttps://peterslab.net

Last Round

Seed

Apr 3, 2023

Total Funding Raised

$380,000

Company Overview

Peter's Lab operates in Healthcare & Life Sciences and is based in Ulsan. Its latest recorded funding round was a Seed round in April 2023.

Peter's Lab is a pet-tech company that develops and distributes pathogen gene analysis kits and a mobile platform for pet disease diagnosis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, D2C Brands, Health IoT

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Peter's Lab Comparables

Compare Peter's Lab with similar companies based on industry and business-model similarity.

Peter's Lab comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pitter Petter
88%
Petwealth
79%
Affordable Pet Labs
74%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Peter's Lab Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 3, 2023
SeedNov 1, 2022
GrantJul 1, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Peter's Lab Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 22, 2026

    Monthly visitors grew 46% MoM.

  • Oct 25, 2024

    Monthly visitors grew 265% MoM, reaching 993.

Book a demo to see all signals

For institutional investors. Book with your work email.

Peter's Lab Filings

Explore SEC and related filing metadata, where available.

Peter's Lab filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Peter's Lab's valuation, stock price, and market status.

Is Peter's Lab a public or private company?

Peter's Lab is a private company.

What is the current stock price of Peter's Lab?

Peter's Lab is a private company, so its shares have no public market price. Caplight tracks Peter's Lab's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Peter's Lab worth (valuation)?

Valuation information for Peter's Lab is not publicly available.

Can I buy Peter's Lab stock?

Peter's Lab shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Peter's Lab's last funding round?

Peter's Lab's most recent funding round was Seed on April 3, 2023.

Who are the main investors in Peter's Lab?

Key investors in Peter's Lab include CNT Tech, Korean Business Angel Network, Korea SMEs and Startups Agency, IPS Ventures, Government of South Korea.

Will Peter's Lab IPO soon?

No public IPO plans have been announced for Peter's Lab.

How can I track Peter's Lab secondary market activity?

Caplight tracks bids, offers, and trades in Peter's Lab's shares on secondary markets.

Firmographic Details

HeadquartersUlsan
Employee Range1
Year Founded2022
Last FundingApr 3, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?